159 related articles for article (PubMed ID: 1757615)
1. Double-blind bilateral paired comparison of 0.05% halobetasol propionate cream and its vehicle in patients with chronic atopic dermatitis and other eczematous dermatoses.
Kantor I; Cook PR; Cullen SI; Willis I; Gibson JR; Stanfield JW
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1184-6. PubMed ID: 1757615
[TBL] [Abstract][Full Text] [Related]
2. A review of two controlled multicenter trials comparing 0.05% halobetasol propionate ointment to its vehicle in the treatment of chronic eczematous dermatoses.
Guzzo CA; Weiss JS; Mogavero HS; Ellis CN; Zaias N; Lowe NJ; Kerdel FA; Milbauer JJ; Bernhard JD; Whitmore C
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1179-83. PubMed ID: 1757614
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, vehicle-controlled paired comparison of halobetasol propionate cream on patients with plaque psoriasis.
Katz HI; Gross E; Buxman M; Prawer SE; Schwartzel EH; Gibson JR
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1175-8. PubMed ID: 1757613
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, comparative clinical trials with halobetasol propionate cream in patients with atopic dermatitis.
Yawalkar SJ; Schwerzmann L
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1163-6. PubMed ID: 1757610
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, multicenter trial of 0.05% halobetasol propionate ointment and 0.05% clobetasol 17-propionate ointment in the treatment of patients with chronic, localized atopic dermatitis or lichen simplex chronicus.
Datz B; Yawalkar S
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1157-60. PubMed ID: 1757608
[TBL] [Abstract][Full Text] [Related]
6. Halobetasol propionate cream by day and halobetasol propionate ointment at night for the treatment of pediatric patients with chronic, localized plaque psoriasis and atopic dermatitis.
Herz G; Blum G; Yawalkar S
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1166-9. PubMed ID: 1757611
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, multicenter, parallel-group trial with 0.05% halobetasol propionate ointment versus 0.1% diflucortolone valerate ointment in patients with severe, chronic atopic dermatitis or lichen simplex chronicus.
Brunner N; Yawalkar S
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1160-3. PubMed ID: 1757609
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of halobetasol propionate ointment in the treatment of plaque psoriasis: report on two double-blind, vehicle-controlled studies.
Bernhard J; Whitmore C; Guzzo C; Kantor I; Kalb RE; Ellis C; Urbach F; Schwartzel EH; Gibson JR
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1170-4. PubMed ID: 1757612
[TBL] [Abstract][Full Text] [Related]
9. Halobetasol Propionate Lotion, 0.05% Provides Superior Hydration Compared to Halobetasol Propionate Cream, 0.05% in a Double-Blinded Study of Occlusivity and Hydration.
Grove G; Zerweck C; Houser T; Andrasfay A; Gauthier B; Holland C; Piacquadio D
J Drugs Dermatol; 2017 Feb; 16(2):140-144. PubMed ID: 28300856
[TBL] [Abstract][Full Text] [Related]
10. Clobetasol propionate emollient 0.05% in the treatment of atopic dermatitis.
Maloney JM; Morman MR; Stewart DM; Tharp MD; Brown JJ; Rajagopalan R
Int J Dermatol; 1998 Feb; 37(2):142-4. PubMed ID: 9542676
[TBL] [Abstract][Full Text] [Related]
11. A phase 2, multicenter, double-blind, randomized, vehicle-controlled clinical study to compare the safety and efficacy of a halobetasol propionate 0.01% lotion and halobetasol propionate 0.05% cream in the treatment of plaque psoriasis.
Kerdel FA; Draelos ZD; Tyring SK; Lin T; Pillai R
J Dermatolog Treat; 2019 Jun; 30(4):333-339. PubMed ID: 30207807
[No Abstract] [Full Text] [Related]
12. A double-blind, multicenter comparison of 0.05% halobetasol propionate ointment and 0.05% clobetasol propionate ointment in patients with chronic, localized plaque psoriasis.
Goldberg B; Hartdegen R; Presbury D; Smith EH; Yawalkar S
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1145-8. PubMed ID: 1757605
[TBL] [Abstract][Full Text] [Related]
13. A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Plaque Psoriasis.
Sugarman JL; Gold LS; Lebwohl MG; Pariser DM; Alexander BJ; Pillai R
J Drugs Dermatol; 2017 Mar; 16(3):197-204. PubMed ID: 28301614
[TBL] [Abstract][Full Text] [Related]
14. The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Doxepin Study Group.
Drake LA; Millikan LE
Arch Dermatol; 1995 Dec; 131(12):1403-8. PubMed ID: 7492129
[TBL] [Abstract][Full Text] [Related]
15. Clobetasol propionate 0.05% lotion in the treatment of moderate to severe atopic dermatitis: a randomized evaluation versus clobetasol propionate emollient cream.
Breneman D; Fleischer AB; Kaplan D; Lebwohl M; Miller B; Pariser D; Rist T; Swinyer L; Liu Y; Foley V
J Drugs Dermatol; 2005; 4(3):330-6. PubMed ID: 15898289
[TBL] [Abstract][Full Text] [Related]
16. Two Multicenter, Randomized, Double-Blind, Parallel Group Comparison Studies of a Novel Foam Formulation of Halobetasol Propionate, 0.05% vs Its Vehicle in Adult Subjects With Plaque Psoriasis.
Bhatia N; Stein Gold L; Kircik LH; Schreiber R
J Drugs Dermatol; 2019 Aug; 18(8):790-796. PubMed ID: 31424709
[TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of a Once-Daily Halobetasol Propionate 0.01% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results of Two Phase 3 Randomized Controlled Trials.
Green LJ; Kerdel FA; Cook-Bolden FE; Bagel J; Lin T; Martin G; Pillai R; Israel R; Ramakrishna T
J Drugs Dermatol; 2018 Oct; 17(10):1062-1069. PubMed ID: 30365586
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, multicenter comparison between 0.05% halobetasol propionate ointment and 0.05% betamethasone dipropionate ointment in chronic plaque psoriasis.
Mensing H; Korsukewitz G; Yawalkar S
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1149-52. PubMed ID: 1757606
[TBL] [Abstract][Full Text] [Related]
19. Two Multicenter, Randomized, Double-Blind, Parallel Group Comparison Studies of a Novel Enhanced Lotion Formulation of Halobetasol Propionate, 0.05% Versus Its Vehicle in Adult Subjects With Plaque Psoriasis.
Pariser D; Bukhalo M; Guenthner S; Kempers S; Shideler S; Gold LS; Tschen E; Berg J; Ferdon MB; Dromgoole S
J Drugs Dermatol; 2017 Mar; 16(3):234-240. PubMed ID: 28301619
[TBL] [Abstract][Full Text] [Related]
20. A comparative, multicenter, double blind trial of 0.05% halobetasol propionate ointment and 0.1% betamethasone valerate ointment in the treatment of patients with chronic, localized plaque psoriasis.
Blum G; Yawalkar S
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1153-6. PubMed ID: 1757607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
